December 21, 2016 By Danielle Kirsh Biom’up receives CE mark approval for first active hemostatic powder
September 8, 2016 By Nic Abraham biom’up announced the enrollment of the first patient in their clinical investigation of HEMOBLAST Bellows
May 18, 2016 By Nic Abraham Biom’Up announced it has received FDA clearance for the HEMOBLAST Bellows IDE pivotal clinical trial design